LUCAT1 and breast carcinoma: The LUCAT1–miR-5582-3p–TCF7L2 axis increased the stem-like properties of breast cancer cells and stemness of breast cancer stem cells via the Wnt/β-catenin pathway, and LUCAT1 expression was related to tumor size, lymph node metastasis, TNM staging, and shorter OS in breast cancer [42].